The Chinese STEMI PPCI Registry (CSPR)

Conditions

ST-segment Elevation Myocardial Infarction (STEMI)

Brief summary

The purpose of this study is to develop a risk score to predict the risks of in-hospital major adverse cardiac events in ST-segment elevation myocardial infarction patients treated by primary percutaneous coronary intervention.

Detailed description

The CSPR trial is an observational clinical trial to derive and validate a readily useable risk score to identify patients at high risk of in-hospital major adverse cardiac events in 5594 patients presenting with a ST-segment elevation myocardial infarction and treated by primary percutaneous coronary intervention.

Luo D, Wang X, Wang L, Hu Z, Zhang B, Xu C, Jiang H, Chen J.

2025-04-01

10.1038/s41598-025-93379-6

Association between Admission Blood Glucose and In-Hospital MACE in Non-Diabetic STEMI (Killip I) Patients Undergoing Primary PCI

Chengzhi Zhang, Jiajuan Yang, Ping Zeng, Rihong Huang, Xinyong Cai et al. (16 authors)

The Heart Surgery Forum2025-01-20

10.59958/hsf.8145

Correlation between abnormal microvascular perfusion and quantitative flow ratio after primary PCI in patients with STEMI.

Xu J, Luo D, Lei Y, Hu Z, Tian H, Chen X, Zhou W, Li M, Liu S, Jin X, Wang Y, Zhang B, Zhou Q, Chen J.

2024-12-311 citations

10.1016/j.ijcard.2024.132949

Association between Systemic Immune-Inflammation Index (SII) and New-Onset In-Hospital Heart Failure in Patients with STEMI after Primary PCI

Huibo Wang, Ying Yang, Ping Zeng, Rihong Huang, Xinyong Cai et al. (13 authors)

Reviews in Cardiovascular Medicine2024-10-249 citations

10.31083/j.rcm2510382

Association between admission blood pressure and spontaneous reperfusion and long-term prognosis in STEMI patients: an observational and multicenter study.

Hu Z, Luo D, Zhou WJ, Xu CW, Chen XZ, Zhang BF, Jin X, Wang Y, Zhang J, Wu H, Liu FY, Lei YH, Li DS, Cai XY, Jiang H, Chen J.

2024-09-182 citations

10.1186/s12872-024-04168-4

Abstract 12391: Correlation of Admission Heart Rate With MACE Among ST-segment Elevation Myocardial Infarction Patients (killip1) Undergoing Primary Percutaneous Coronary Intervention

Jian Yang, Ping Zeng

Circulation2023-11-07

10.1161/circ.148.suppl_1.12391

Predictive value of STEP-HF risk score in patients with ST-segment elevation myocardial infarction (Killip I) treated by primary percutaneous coronary intervention

Jing Chen, Xiao‐Jiang Hao, Jian Zhang, Bing‐Shen Huang, Dan Luo et al. (12 authors)

European Heart Journal2023-11-01

10.1093/eurheartj/ehad655.1522

INTRA-AORTIC BALLOON PUMP REDUCES 30-DAY MORTALITY IN EARLY-STAGE CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION ACCORDING TO SCAI CLASSIFICATION

Da Luo, Rihong Huang, Xiaoying Wang, Jing Zhang, Xinyong Cai et al. (13 authors)

Shock2023-08-0415 citations

10.1097/shk.0000000000002184

Angio-Based Coronary Functional Assessment Predicts 30-Day New-Onset Heart Failure After Acute Myocardial Infarction

Da Luo, Hui Wu, Wenjie Zhou, Jing Zhang, Xing Jin et al. (10 authors)

ESC Heart Failure2023-07-1610 citations

10.1002/ehf2.14452

Interventions

OTHERno intervention

no intervention

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

No

Inclusion criteria

1. Age≥18 2. ST-segment elevation myocardial infarction was defined according to the universal definition of myocardial infarction 3. STEMI treated by pPCI

Exclusion criteria

1. Patient with heart failure in admission 2. STEMI with symptom-onset-to-balloon time\>24h 3. pPCI was not successful or only underwent coronary angiography 4. Killip class ≥II in admission

Design outcomes

Primary

Measure	Time frame	Description
in-hospital acute de novo heart failure	in-hospital outcome, until discharge	Killip class ≥II
cardiogenic shock	in-hospital outcome, until discharge	according to the universal definition
death	in-hospital outcome, until discharge	according to the universal definition

Countries

China

Outcome results

None listed